CIGNA (CI) Healthcare Profit Growth Strong - Jefferies
Jefferies lifted estimates and its price target on CIGNA (NYSE: CI) from $74 to $78 while reiterating a Buy rating.
Analyst David Windley comments, "CI's fundamentals are continuing to advance well. The company's solid 21% 1Q13 EPS beat and 2.5% EPS guidance raise start 2013 off nicely. Like others, management has eased off its confidence in growing 2014 earnings due to the MA rate cuts. They will reassess and provide an update later in the year. We are also still awaiting the PBM decision."
The firm raised FY 2013 EPS from $6.34 to $6.47.
For an analyst ratings summary and ratings history on CIGNA click here. For more ratings news on CIGNA click here.
Shares of CIGNA closed at $68.07 yesterday, with a 52 week range of $39.01-$68.87.
Analyst David Windley comments, "CI's fundamentals are continuing to advance well. The company's solid 21% 1Q13 EPS beat and 2.5% EPS guidance raise start 2013 off nicely. Like others, management has eased off its confidence in growing 2014 earnings due to the MA rate cuts. They will reassess and provide an update later in the year. We are also still awaiting the PBM decision."
The firm raised FY 2013 EPS from $6.34 to $6.47.
For an analyst ratings summary and ratings history on CIGNA click here. For more ratings news on CIGNA click here.
Shares of CIGNA closed at $68.07 yesterday, with a 52 week range of $39.01-$68.87.